Tech Drag, Neuren Surge: ASX 200 Wavers Amid Xero Dive and Patent Wins

3 min read | June 26, 2025 06:04 AM BST | By Team Kalkine Media

Highlights

  • Xero slides on news of a major acquisition, weighing on tech

  • Neuren Pharmaceuticals rises following US patent approval

  • DroneShield and Pointsbet attract interest on contract and M&A news

Australian shares opened softer on Thursday with the ASX 200 slipping in mid-session trade as weakness in the technology sector offset gains in pharmaceuticals and defence-related names. Market sentiment fluctuated through the morning as a series of corporate announcements shaped the direction of individual stocks.

The tech sector was under pressure following a sharp decline in a leading accounting platform while pharmaceuticals posted notable gains on regulatory updates from the United States.

Xero Falls on Acquisition Announcement

Xero Ltd (ASX:XRO) resumed trade after a brief halt and declined as the market reacted to its proposed acquisition of US-based fintech Melio Payments. The company also announced a capital raise to fund the transaction, which added to concerns about shareholder dilution.

The decline in Xero weighed on broader sentiment within the tech segment, making it the day’s underperformer across key indices.

Neuren Rallies on US Patent Grant

Neuren Pharmaceuticals Ltd (ASX:NEU) saw a sharp intraday move higher after announcing it had secured a patent from the US Patent Office. The approval covers NNZ-2591, Neuren’s experimental treatment for Pitt Hopkins syndrome, a rare neurological condition with limited therapeutic options.

The patent protection will extend until the next decade, supporting the company’s long-term development plans in the rare disease space. This update sparked positive momentum across the broader biotech category.

DroneShield Advances After Securing European Defence Deal

DroneShield Ltd (ASX:DRO) continued to trade strongly following confirmation of a contract with a European military partner. The agreement involves its anti-drone technology and marked a second consecutive day of gains for the defence technology firm.

Investors welcomed the developments, with activity surging after the announcement was made public earlier this week. The company remains focused on delivering portable counter-drone solutions to global security partners.

Pointsbet Receives Revised Takeover Proposal

Pointsbet Holdings Ltd (ASX:PBH) confirmed it had received an updated acquisition proposal from Japanese-based Mixi after an earlier scheme involving another bidder did not proceed. The latest offer involves a cash-based structure and aims to secure a full takeover of the ASX-listed bookmaker.

Market Movers in Small Caps and Resources

Several small cap stocks posted significant intraday moves. Opyl Ltd (ASX:OPL), a company using artificial intelligence in drug discovery, gained attention after revealing a strategic allocation of treasury funds into digital assets, including Bitcoin via an exchange-traded fund. The move aligns with the company’s broader tech-forward initiatives.

Rapid Critical Metals Ltd (ASX:RCM) also recorded strong gains following its successful placement to fund full ownership of two silver projects in New South Wales. The company is preparing to initiate further exploration at the Webbs site.

Elsewhere, Humm Group Ltd (ASX:HUM) extended its rally following the confirmation of a takeover offer from its chairman’s family office, while Locksley Resources Ltd (ASX:LKY) announced its dual listing on the OTCQB market to broaden access to North American investors.

Top Performers and Decliners

Among the top gainers were uranium and lithium-exposed names including Vital Metals Ltd (ASX:VML) and Altair Minerals Ltd (ASX:ALR). On the downside, weaker performances came from junior explorers and early-stage miners, particularly in the gold and energy segments, with several names retreating from earlier highs.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Limited, Company No. 12643132 (Kalkine Media, we or us) and is available for personal and non-commercial use only. Kalkine Media is an appointed representative of Kalkine Limited, who is authorized and regulated by the FCA (FRN: 579414). The non-personalised advice given by Kalkine Media through its Content does not in any way endorse or recommend individuals, investment products or services suitable for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a qualified financial planner and/or adviser. No liability is accepted by Kalkine Media or Kalkine Limited and/or any of its employees/officers, for any investment loss, or any other loss or detriment experienced by you for any investment decision, whether consequent to, or in any way related to this Content, the provision of which is a regulated activity. Kalkine Media does not intend to exclude any liability which is not permitted to be excluded under applicable law or regulation. Some of the Content on this website may be sponsored/non-sponsored, as applicable. However, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music/video that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music or video used in the Content unless stated otherwise. The images/music/video that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.


Sponsored Articles


Investing Ideas

Previous Next